These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New therapeutic options for the metabolic syndrome: what's next? Flordellis CS; Ilias I; Papavassiliou AG Trends Endocrinol Metab; 2005 Aug; 16(6):254-60. PubMed ID: 16002303 [TBL] [Abstract][Full Text] [Related]
4. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Stahl SM; Mignon L; Meyer JM Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394 [TBL] [Abstract][Full Text] [Related]
5. Uncloaking the genetic determinants of metabolic syndrome. Lahiry P; Pollex RL; Hegele RA J Nutrigenet Nutrigenomics; 2008; 1(3):118-25. PubMed ID: 19776621 [TBL] [Abstract][Full Text] [Related]
6. Prioritization of candidate disease genes for metabolic syndrome by computational analysis of its defining phenotypes. Tiffin N; Okpechi I; Perez-Iratxeta C; Andrade-Navarro MA; Ramesar R Physiol Genomics; 2008 Sep; 35(1):55-64. PubMed ID: 18612082 [TBL] [Abstract][Full Text] [Related]
7. Integration--a key to success in the genetic dissection of complex diseases? Yagil Y; Yagil C Trends Cardiovasc Med; 2006 Feb; 16(2):35-8. PubMed ID: 16473759 [TBL] [Abstract][Full Text] [Related]
8. Genetic aspects of hypertension and metabolic disease in the obstructive sleep apnoea-hypopnoea syndrome. Riha RL; Diefenbach K; Jennum P; McNicholas WT; Sleep Med Rev; 2008 Feb; 12(1):49-63. PubMed ID: 18201663 [TBL] [Abstract][Full Text] [Related]
9. Functional genomics in hypertension. McBride MW; Graham D; Delles C; Dominiczak AF Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):145-51. PubMed ID: 16481881 [TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Andreassi MG Mutat Res; 2009 Jul; 667(1-2):35-43. PubMed ID: 19028510 [TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study for type 2 diabetes: clinical applications. Lyssenko V; Groop L Curr Opin Lipidol; 2009 Apr; 20(2):87-91. PubMed ID: 19276887 [TBL] [Abstract][Full Text] [Related]
12. Genetic dissection of type 2 diabetes. Ridderstråle M; Groop L Mol Cell Endocrinol; 2009 Jan; 297(1-2):10-7. PubMed ID: 19000735 [TBL] [Abstract][Full Text] [Related]
13. Genetic factors in type 2 diabetes: the end of the beginning? O'Rahilly S; Barroso I; Wareham NJ Science; 2005 Jan; 307(5708):370-3. PubMed ID: 15662000 [TBL] [Abstract][Full Text] [Related]
15. Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype. Ashrafian H; Watkins H J Am Coll Cardiol; 2007 Mar; 49(12):1251-64. PubMed ID: 17394955 [TBL] [Abstract][Full Text] [Related]
16. Human genetics of the metabolic syndrome. Chuang LM Asia Pac J Clin Nutr; 2008; 17 Suppl 1():43-6. PubMed ID: 18296298 [TBL] [Abstract][Full Text] [Related]
17. Genomics and large scale phenotypic databases. Winkelmann BR Pharmacogenomics; 2001 Feb; 2(1):3-5. PubMed ID: 11258195 [TBL] [Abstract][Full Text] [Related]
18. [Identifying different susceptibility loci associated with early onset diabetes and cardiovascular disease in Mexican families]. Canizales-Quinteros S; Huertas-Vázquez A; Riba-Ramírez L; Monroy-Guzmán A; Domínguez-López A; Romero-Hidalgo S; Aguilar-Salinas C; Rodríguez-Torres M; Ramírez-Jiménez S; Tusié-Luna MT Gac Med Mex; 2005; 141(2):115-22. PubMed ID: 15892459 [TBL] [Abstract][Full Text] [Related]